wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38865046-24D4B057-DE82-4A7D-9EE3-5940C3EAF087
Q38865046-24D4B057-DE82-4A7D-9EE3-5940C3EAF087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38865046-24D4B057-DE82-4A7D-9EE3-5940C3EAF087
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.
P2860
Q38865046-24D4B057-DE82-4A7D-9EE3-5940C3EAF087
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38865046-24D4B057-DE82-4A7D-9EE3-5940C3EAF087
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4dd57d58cf9528a059470a51df37f0c9cd02c4a7
P2860
The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma.